Cellex is a medical device company dedicated to innovating and developing diagnostic tests that are fast, accurate, as well as easy and inexpensive to use. Cellex currently develops, manufactures, and markets 2 versions of a real-time Neuraminidase Inhibitor (NI) assay (one is specific for influenza neuraminidase and the other one is not specific for influenza neuraminidase). Designed for influenza and drug resistance detection as well as for high-throughput drug candidate screening, the assay is cost-effective, easy-to-use, and more sensitive than leading assays currently available on the market. The convenience offered by the assay helps our customers significantly cut their labor costs. Our tests are currently for research use only. 

At Cellex, we strive to develop fast, accurate, and cost-effective medical tests that can be used to help save lives. We are proud that we are making a difference in the world!

Mission and Philosophy

Our mission is to make a positive contribution to the world by advancing diagnostic technologies and developing innovative diagnostic tests. Our direction is driven by the need of those whom we serve, including researchers, physicians, and patients.